Mounjaro and Skin Issues: What Changes to Your Skin Mean

Injection-site reactions (redness, itching, bruising at the pen site) are the most commonly reported skin-related side effect in tirzepatide trials.
A small number of people report hair shedding, typically linked to rapid weight loss rather than the medicine itself.
Serious allergic skin reactions (widespread rash, swelling of the face or throat, difficulty breathing) require emergency help immediately.
Rotating your injection site every week reduces localised skin reactions and is recommended in the Mounjaro Patient Information Leaflet.

Skin changes are among the less-discussed side effects of tirzepatide, yet they come up regularly in clinical practice. Some are minor and settle on their own; a few deserve prompt attention. Understanding which is which is the practical decision this page helps you make — and it starts with knowing that Mounjaro is a prescription-only medicine assessed individually by a clinician, so any skin concern that worries you should go back to your prescriber first. The NHS tirzepatide medicines page lists the reported reactions from clinical trial data and is worth bookmarking alongside your treatment.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to read the skin changes Mounjaro can cause — and what to do about each one

Injection-site reactions: the most common skin complaint

Most people who notice a skin issue on Mounjaro trace it to the injection site itself. After pressing the KwikPen against your abdomen, thigh or upper arm, it is not unusual to see a small red patch, some itching or mild bruising in the hours that follow. This happens because the medicine is delivered into the fatty tissue just under the skin, and the body's local immune response can produce that familiar warmth-and-redness pattern.

The good news is that these reactions almost always fade within a day or two and rarely interfere with treatment. The practical fix is straightforward: rotate your injection site every week so the same patch of skin gets a rest. Many people find it easier to keep a loose mental map (abdomen one week, thigh the next) rather than relying on memory. Keeping the pen at room temperature for a few minutes before injecting (take it out of the fridge door while you make your morning coffee) can also reduce the sting that sometimes precedes a local reaction.

If a site becomes hard, lumpy or inflamed for more than a few days, or if you notice changes spreading beyond the immediate area, mention it to your prescriber. It may simply need a change of injection technique, but it is worth a proper look.

Hair thinning: is Mounjaro actually the cause?

Hair shedding appears in feedback from people on tirzepatide treatment, and it causes understandable anxiety. The clinical picture is more nuanced than headlines suggest. Significant or rapid weight loss (regardless of how it is achieved) is a recognised trigger for a process called telogen effluvium, in which hair follicles temporarily shift into a resting phase. The result is increased shedding, usually two to four months after the period of most rapid loss.

This does not mean the medicine is damaging your hair follicles. It means your body is responding to the metabolic shift of losing weight quickly. In most cases, regrowth follows once weight stabilises and nutrition catches up. Protein intake and micronutrient levels matter here, a common pattern in people losing weight through appetite reduction is that calorie restriction inadvertently cuts protein, which the hair follicle cycle depends on.

If you are concerned about hair changes during treatment, your prescriber is the right person to assess whether the degree of shedding is within expected range or warrants investigation. There is useful background on common issues people raise about Mounjaro if you want to read wider before your next check-in.

Rashes, itching and allergic reactions: knowing the spectrum

Rash and itching that go beyond the injection site sit on a spectrum, and the position on that spectrum matters. A mild, transient itch or a small raised weal that appears and disappears within hours is usually a minor skin sensitivity, not uncommon with subcutaneous injections. It can often be managed with cool compresses or antihistamines, but check with your prescriber or pharmacist before adding any new medicine, including over-the-counter antihistamines, because of potential interactions.

At the serious end of the spectrum is a genuine allergic reaction to tirzepatide. Signs include a spreading rash across a large area of the body, swelling of the lips, face or throat, tightening in the chest or difficulty breathing, or feeling faint. These are not ordinary side effects. They require emergency medical help straight away, call 999 or go to A&E. Treatment must be paused and your prescriber notified.

The MHRA Yellow Card scheme allows patients to report suspected side effects directly to the regulator. If you experience an unexpected or severe skin reaction, reporting it there contributes to the ongoing safety monitoring of tirzepatide, a Black Triangle (▼) medicine still under additional MHRA surveillance. For a broader picture of how Mounjaro is monitored and what the trial programme found, the tirzepatide overview covers the clinical background in detail.

When skin changes might signal something to watch, and what shapes your decision

Most skin changes on Mounjaro are minor, site-specific and self-resolving. The decision about whether to wait, self-manage or contact your prescriber comes down to three things: how widespread the change is, how long it has been present, and whether it is accompanied by any systemic symptoms such as fever, breathlessness or significant swelling.

Localised, short-lived and mild: monitor, rotate your injection site, and mention it at your next scheduled review. Persistent, spreading or accompanied by anything beyond the skin: contact your prescriber before the next injection is due. Severe, systemic or rapidly worsening: seek emergency care first and contact your prescriber as soon as possible after. Some people also notice other physical changes worth knowing about, and our page on tirzepatide and tachycardia explains what an elevated heart rate during treatment can mean and when it needs attention.

It is worth noting that some skin conditions can also improve during tirzepatide treatment, people with obesity-related conditions such as acanthosis nigricans (darkened, thickened skin patches often linked to insulin resistance) sometimes find these change as metabolic markers improve. This is not a licensed claim for the medicine; it is an observation worth discussing with your GP or dermatologist if relevant to you. Similarly, if you have noticed any changes to your vision since starting treatment, our guidance on Mounjaro and eye issues sets out what is currently understood and when to seek a professional review.

If you are considering starting Mounjaro and want to understand more about how the treatment is assessed, including how skin and other health factors are weighed in a clinical review, take a look at our weight-loss treatment overview. The cost of treatment through a private regulated pharmacy is a fair question too, there is a transparent breakdown on the Eli Lilly UK price increase page that explains how market pricing has shifted since late 2025.

Our clinical team reviews every consultation personally (a real prescriber reads your answers, not an automated system) so any skin concerns you flag at the point of applying are seen by someone qualified to weigh them properly. If you already have questions before you start, including whether anything you have noticed, such as disrupted sleep since starting Mounjaro, is worth raising with a prescriber, our support team is available seven days a week.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions